Ginkgo Bioworks Holdings, Inc.

DNANYSE· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$170.2M

▼ 25.1% YoY

Net Income

-$312.8M

▲ 42.8% YoY

EPS

$-5.64

▲ 46.5% YoY

Cash

$167.2M

▼ 70.2% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.